← Back
$MYGN All transactions

MYRIAD GENETICS INC

A

$ Value

$0

Shares

23,697

Price

$0

Filed

Feb 3

Insider

Name

Haas Kevin Richard

Title

Chief Technology Officer

CIK

0001843872

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

202,332

Footnotes

Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026.

Filing Info

Accession No.

0001843872-26-000003

Form Type

4

Issuer CIK

0000899923

Haas Kevin Richard's History

Date Ticker Type Value
2026-04-10 VCYT A $0
2026-02-02 MYGN A $0

Other Insiders at MYGN (90d)

Insider Bought Sold Last
Verratti Mark
Chief Operating Officer
2026-04-14
Muzzey Dale
Chief Scientific Officer
2026-04-14
Wheeler Benjamin Richard
Chief Financial Officer
2026-02-02